Efficacy of Telavancin in Comparison to Linezolid in a Porcine Model of Severe Methicillin-Resistant Staphylococcus aureus Pneumonia

Current guidelines recommend vancomycin and linezolid as first-line agents against methicillin-resistant Staphylococcus aureus (MRSA) nosocomial pneumonia. Telavancin is a potential new therapeutic alternative, specifically in monomicrobial MRSA pneumonia. This study compared the efficacies of telav...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Battaglini, D., Motos, A., Li Bassi, G., Yang, H., Pagliara, F., Yang, M., Aguilera Xiol, E., Meli, A., Bobi, J., Frigola, G., Senussi, T., Idone, F., Travierso, C., Chiurazzi, C., Fernandez-Barat, L., Rigol, M., Ramirez, J., Pelosi, P., Chiumello, D., Antonelli, M., Nicolau, D. P., Bringue, J., Artigas, A., Guerrero, L., Soy, D., Torres, A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2020
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927834/
https://ncbi.nlm.nih.gov/pubmed/33046500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01009-20
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia